This Article Full Text Full Text (PDF) Data Supplement Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crawley, J. T.B. Articles by Lupu, F. Search for Related Content PubMed PubMed Citation Articles by Crawley, J. T.B. Articles by Lupu, F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Coronary Artery Disease Related Collections Gene expression Gene regulation Mechanism of atherosclerosis/growth factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:218.)
© 2002 American Heart Association, Inc.

Vascular Biology

Expression and Localization of Tissue Factor Pathway Inhibitor-2 in Normal and Atherosclerotic Human Vessels

James T.B. Crawley; David A. Goulding; Valérie Ferreira; Nicholas J. Severs; Florea Lupu

From the Thrombosis Research Institute (J.T.B.C., D.A.G., F.L.), London, England; the Oklahoma Medical Research Foundation (J.T.B.C., F.L.), Oklahoma City, Oklahoma; the Center for Molecular Microbiology (D.A.G.), Imperial College, London, England; the Academic Medical Center (V.F.), University of Amsterdam, Amsterdam, Netherlands; and the National Heart and Lung Institute (N.J.S.), Imperial College, London, England.

Reprint requests to Dr Florea Lupu, Oklahoma Medical Research Foundation, Cardiovascular Biology Research Program, Acree-Woodworth Research Building, 825 NE 13th St, Oklahoma City, OK 73104. E-mail florea-lupu{at}omrf.ouhsc.edu

Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type, serine protease inhibitor with inhibitory activity toward activated factor XI, plasma kallikrein, plasmin, certain matrix metalloproteinases, and the tissue factor:activated factor VII complex. In this study, we investigated TFPI-2 expression and localization in normal and atherosclerotic human arteries by using in situ hybridization and immunohistochemical techniques. In healthy human blood vessels, TFPI-2 was detected in the vascular endothelium alone. In human atherosclerotic tissues, TFPI-2 expression was assigned to macrophages, T cells, endothelial cells, and smooth muscle cells. Western blot analysis for TFPI-2 confirmed its production by cultured human aortic smooth muscle cells, U937 cells (monocytes), and Jurkat (T cell) cell lines. Reverse transcription–polymerase chain reaction revealed similar TFPI-2 expression levels in both monocytes and macrophages in culture. Electron microscopic study with immunogold labeling revealed the association of TFPI-2 antigen with both the extracellular matrix and plasma membranes. TFPI-2 antigen was detected in some areas of atheroma that also stained positively for both tissue factor and factor VII. Moreover, detection of TFPI-2 in close spatial proximity to plasmin/plasminogen on macrophages, on endothelial cells, and in matrix-rich areas highlighted its possible functional significance in the regulation of plasmin activity and downstream proteolytic mechanisms that occur in the atherosclerotic lesion.

Key Words: atherosclerosis • matrix metalloproteinases • tissue factor pathway inhibitor-2 • plasmin • tissue factor

This article has been cited by other articles:

				C. Consoli, E. Martelli, M. D'Adamo, R. Menghini, D. Arcelli, O. Porzio, A. Pandolfi, G. R. Pistolese, A. Consoli, R. Lauro, et al. Insulin Resistance Affects Gene Expression in Endothelium Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): e7 - e9. [Full Text] [PDF]

				L. Ivanciu, R. D. Gerard, H. Tang, F. Lupu, and C. Lupu Adenovirus-Mediated Expression of Tissue Factor Pathway Inhibitor-2 Inhibits Endothelial Cell Migration and Angiogenesis Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 310 - 316. [Abstract] [Full Text] [PDF]

				Z. Xu, D. Maiti, W. Kisiel, and E. J. Duh Tissue Factor Pathway Inhibitor-2 Is Upregulated by Vascular Endothelial Growth Factor and Suppresses Growth Factor-Induced Proliferation of Endothelial Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2819 - 2825. [Abstract] [Full Text] [PDF]

				A. E. Schmidt, H. S. Chand, D. Cascio, W. Kisiel, and S. P. Bajaj Crystal Structure of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 in Complex with Trypsin: IMPLICATIONS FOR KD1 SPECIFICITY OF INHIBITION J. Biol. Chem., July 29, 2005; 280(30): 27832 - 27838. [Abstract] [Full Text] [PDF]

				B. S. F. Tang, K.-h. Chan, V. C. C. Cheng, P. C. Y. Woo, S. K. P. Lau, C. C. K. Lam, T.-l. Chan, A. K. L. Wu, I. F. N. Hung, S.-y. Leung, et al. Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229E J. Virol., May 15, 2005; 79(10): 6180 - 6193. [Abstract] [Full Text] [PDF]

				H. S. Chand, X. Du, D. Ma, H. D. Inzunza, S. Kamei, D. Foster, S. Brodie, and W. Kisiel The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice Blood, February 1, 2004; 103(3): 1069 - 1077. [Abstract] [Full Text] [PDF]